Table 2. Principles of bacterial robot for cancer therapy development.
|
AIM |
APPROACH |
POSSIBLE WAY |
|
Choice of bacterium |
||
|
Immunostimulation |
Wild type strains |
The natural immune response |
|
Genetically modified strains |
Additional immunogenic components |
|
|
A therapeutic or diagnostic tool |
Production of prodrugs and/or diagnostic molecules inside the tumor |
Secretion of therapeutic molecules (enzymes, toxins, etc.) |
|
Production of therapeutic molecules followed by bacterial cell lysis |
||
|
Delivery of (pro)drugs |
Transfer of genetic material (miRNA) |
|
|
Transfer of cytotoxic molecules and mediators (photosensitizers, activators, etc.) |
||
|
Delivery to the tumor tissue |
||
|
Getting the tumor |
Targeting |
Passive migration with blood flow |
|
Natural tropism, moving of anaerobes towards hypoxic tumor area, chemotaxis |
||
|
Increased tropism, introduction of adhesive components |
||
|
Moving towards the tumor |
Controlling |
External control (magnetic, thermal fields etc.) |
|
Penetration into the cancer cell |
"Module of the invasion" |
|
|
Release of therapeutic cargo |
Release of cytoplasmic contents |
Externally controlled lysis |
|
Lysis controlled by bacterial population density |
||
|
Containers loaded with therapeutics |
Activation or degradation inside the tumor area |
|
|
Biosafety |
||
|
For the patient |
Утилизация бактерии после выполнения миссии |
Sensitivity to antibiotics |
|
Auxotrophy |
||
|
Induced suicidal genes |
||
|
For the environment |
Модифицированные или искусственные штаммы, неспособные размножаться; ослабленные штаммы, неспособные выжить в окружающей среде |
Genetically modified strains |
|
Strains with minimal or reduced genome |
||